Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes... Show more
CDXS is expected to report earnings to rise 41.70% to -14 cents per share on July 30
Q2'26
Est.
$-0.14
Q1'26
Beat
by $0.06
Q4'25
Beat
by $0.15
Q3'25
Missed
by $0.07
Q2'25
Beat
by $0.03
The last earnings report on May 07 showed earnings per share of -10 cents, beating the estimate of -15 cents. With 145.60K shares outstanding, the current market capitalization sits at 214.06M.